UY24556A1 - Comprimidos con alto contenido de famciclovir - Google Patents

Comprimidos con alto contenido de famciclovir

Info

Publication number
UY24556A1
UY24556A1 UY24556A UY24556A UY24556A1 UY 24556 A1 UY24556 A1 UY 24556A1 UY 24556 A UY24556 A UY 24556A UY 24556 A UY24556 A UY 24556A UY 24556 A1 UY24556 A1 UY 24556A1
Authority
UY
Uruguay
Prior art keywords
famciclovir
tablets
content
tablet
active ingredient
Prior art date
Application number
UY24556A
Other languages
English (en)
Inventor
Greenway John
Slater Mary
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of UY24556A1 publication Critical patent/UY24556A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

Un comprimido farmacéutico en el que el famciclovir es el ingrediente activo y en el porcentaje en peso de famciclovir en el comprimido es del 85% o mayor.
UY24556A 1996-01-16 1997-05-16 Comprimidos con alto contenido de famciclovir UY24556A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
UY24556A1 true UY24556A1 (es) 2001-08-27

Family

ID=10787105

Family Applications (2)

Application Number Title Priority Date Filing Date
UY24437A UY24437A1 (es) 1996-01-16 1997-01-10 Procedimiento para preparar productos farmaceuticos
UY24556A UY24556A1 (es) 1996-01-16 1997-05-16 Comprimidos con alto contenido de famciclovir

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY24437A UY24437A1 (es) 1996-01-16 1997-01-10 Procedimiento para preparar productos farmaceuticos

Country Status (38)

Country Link
US (1) US6765007B1 (es)
EP (1) EP0874632B1 (es)
JP (2) JP4711360B2 (es)
KR (1) KR100338829B1 (es)
CN (1) CN1132582C (es)
AP (2) AP747A (es)
AR (1) AR005456A1 (es)
AT (1) ATE220910T1 (es)
AU (1) AU713090B2 (es)
BG (1) BG63488B1 (es)
BR (1) BR9706982A (es)
CY (1) CY2390B1 (es)
CZ (1) CZ287205B6 (es)
DE (1) DE69714215T2 (es)
DK (1) DK0874632T3 (es)
DZ (1) DZ2159A1 (es)
EA (1) EA001946B1 (es)
EG (1) EG23684A (es)
ES (1) ES2180922T3 (es)
GB (1) GB9600847D0 (es)
HK (1) HK1016473A1 (es)
HU (1) HU225472B1 (es)
IL (1) IL124913A0 (es)
MX (1) MX9805713A (es)
MY (1) MY127527A (es)
NO (1) NO315689B1 (es)
NZ (1) NZ326769A (es)
OA (1) OA10812A (es)
PE (1) PE35498A1 (es)
PL (1) PL187291B1 (es)
PT (1) PT874632E (es)
SK (1) SK282132B6 (es)
TR (1) TR199800954T2 (es)
TW (1) TW434016B (es)
UA (1) UA63897C2 (es)
UY (2) UY24437A1 (es)
WO (1) WO1997025990A1 (es)
ZA (1) ZA97310B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
CN102470237A (zh) 2009-06-26 2012-05-23 塔里斯生物医药公司 用于可植入药物递送装置的固体药物片剂
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
ATE133068T1 (de) * 1991-01-30 1996-02-15 Wellcome Found Wasserlösliche tabletten
RU2126255C1 (ru) 1991-05-15 1999-02-20 Йель Юниверсити Способ получения противоопухолевого эффекта у млекопитающих
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
CY2390B1 (en) 2004-09-10
EP0874632A1 (en) 1998-11-04
SK282132B6 (sk) 2001-11-06
PT874632E (pt) 2002-10-31
NO315689B1 (no) 2003-10-13
NO983259D0 (no) 1998-07-15
JP2000503311A (ja) 2000-03-21
JP4711360B2 (ja) 2011-06-29
NO983259L (no) 1998-07-15
JP2009091362A (ja) 2009-04-30
DZ2159A1 (fr) 2002-12-01
EA001946B1 (ru) 2001-10-22
BG102638A (en) 1999-07-30
SK95698A3 (en) 1999-01-11
PL187291B1 (pl) 2004-06-30
ZA97310B (en) 1997-10-23
CN1132582C (zh) 2003-12-31
AP9801298A0 (en) 1998-09-30
AP1114A (en) 2002-10-18
ATE220910T1 (de) 2002-08-15
NZ326769A (en) 2000-05-26
AU1541897A (en) 1997-08-11
AU713090B2 (en) 1999-11-25
EG23684A (en) 2007-05-09
ES2180922T3 (es) 2003-02-16
PE35498A1 (es) 1998-08-07
BG63488B1 (bg) 2002-03-29
WO1997025990A1 (en) 1997-07-24
UA63897C2 (en) 2004-02-16
AR005456A1 (es) 1999-06-23
KR100338829B1 (ko) 2002-07-18
CZ287205B6 (en) 2000-10-11
PL327922A1 (en) 1999-01-04
MY127527A (en) 2006-12-29
OA10812A (en) 2003-01-29
AP747A (en) 1999-05-03
CN1208350A (zh) 1999-02-17
BR9706982A (pt) 1999-07-20
CZ225498A3 (cs) 1998-12-16
DK0874632T3 (da) 2002-11-11
TR199800954T2 (xx) 1998-10-21
DE69714215T2 (de) 2003-01-23
HUP9901021A2 (hu) 1999-08-30
HK1016473A1 (en) 1999-11-05
HU225472B1 (en) 2006-12-28
KR19990077229A (ko) 1999-10-25
DE69714215D1 (de) 2002-08-29
EA199800573A1 (ru) 1999-02-25
AP9700911A0 (en) 1997-01-31
EP0874632B1 (en) 2002-07-24
HUP9901021A3 (en) 2000-08-28
MX9805713A (es) 1998-10-31
IL124913A0 (en) 1999-01-26
UY24437A1 (es) 1997-06-06
GB9600847D0 (en) 1996-03-20
TW434016B (en) 2001-05-16
US6765007B1 (en) 2004-07-20

Similar Documents

Publication Publication Date Title
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
WO1994027589A3 (en) Antidepressant dosage form
ES2167609T3 (es) Formulaciones de quinolona inyectables.
ES2161690T3 (es) Formulaciones farmaceuticas.
NO981746L (no) Utlevering av biologisk aktive polypeptider
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
ES2036177T3 (es) Maltitol en polvo directamente compresible y su procedimiento de preparacion.
DE3875108T2 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
ATE187640T1 (de) Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten
NO995127D0 (no) Stabiliserte tibolonblandinger
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
ES2101317T3 (es) Medicamento para aumentar el nivel de testosterona.
UY24556A1 (es) Comprimidos con alto contenido de famciclovir
ATE87468T1 (de) Antacidatabletten.
ATA147691A (de) Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung
GB2295966B (en) Direct compression tablets
TR199801439T2 (xx) Herpes simpleks enfeksiyonlar�n�n kombine terapisinde n�kleosit analoglar�.
ATE207357T1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
DE69616591D1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
ECSP971997A (es) Nueva formulacion de un producto farmaceutico
TR199901237T2 (xx) Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�.
KR950007852A (ko) 우라실을 유효성분으로 함유하는 관절염 치료제
ES2085656T3 (es) Forma de administracion peroral de medicamentos peptidicos, en particular insulina.
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20170516